Institutional investors hold a majority ownership of BIIB through the 90.12% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT CORP. Bought 195.0 Thousand shares of Biogen
WAVERTON INVESTMENT MANAGEMENT L... Bought 192.1 Thousand shares of Biogen